Conventional X-rays in the diagnosis and follow-up of vertebral fractures in patients with acromegaly: a real-life study.
Acromegaly
IGF-1
Vertebral fractures
X-ray imaging
Journal
Journal of endocrinological investigation
ISSN: 1720-8386
Titre abrégé: J Endocrinol Invest
Pays: Italy
ID NLM: 7806594
Informations de publication
Date de publication:
05 Sep 2023
05 Sep 2023
Historique:
received:
15
12
2022
accepted:
28
06
2023
medline:
5
9
2023
pubmed:
5
9
2023
entrez:
5
9
2023
Statut:
aheadofprint
Résumé
To explore the role of conventional X-ray imaging in detecting vertebral fractures (VFs) in patients with acromegaly, both at diagnosis of disease and at the last clinical visit. The risk factors for VFs were also evaluated. A retrospective cohort study was conducted on 60 consecutive patients with acromegaly, in a tertiary referral centre. Thoracolumbar spine radiography (X-spine) was performed at the last clinical visit during the follow-up in order to detect VFs. Routine chest radiograph, performed as a part of the general evaluation at diagnosis of acromegaly, were retrospectively analysed to screen for baseline VFs. At diagnosis of acromegaly, chest X-ray revealed that 10 (17%) patients had VFs. Of the 50 patients without VFs at diagnosis of acromegaly, 33 (66%) remained unfractured at the last clinical visit (median [IQR] time, 144 [96-192] months after the diagnosis of acromegaly), whereas 17 (34%) had VFs. Overall, 22 patients (37%) had novel VFs detected on X-spine including five patients with previous VFs. Risk factor for incident VFs was the presence of hypogonadism at diagnosis of acromegaly (p = 0.016). In acromegaly patients, conventional X-rays can detect vertebral fractures early at diagnosis of acromegaly. They can also reveal incident VFs, which may occur several years later even in patients without VFs at diagnosis, above all in relation to hypogonadism.
Identifiants
pubmed: 37668886
doi: 10.1007/s40618-023-02148-7
pii: 10.1007/s40618-023-02148-7
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2023. The Author(s), under exclusive licence to Italian Society of Endocrinology (SIE).
Références
Giustina A, Mazziotti G, Canalis E (2008) Growth hormone, insulin-like growth factors, and the skeleton. Endocr Rev 29:535–559. https://doi.org/10.1210/er.2007-0036
doi: 10.1210/er.2007-0036
pubmed: 18436706
pmcid: 2726838
Gadelha MR, Kasuki L, Lim DST, Fleseriu M (2019) Systemic complications of acromegaly and the impact of the current treatment landscape: an update. Endocr Rev 40:268–332. https://doi.org/10.1210/er.2018-00115
doi: 10.1210/er.2018-00115
pubmed: 30184064
Mazziotti G, Lania AGA, Canalis E (2019) Bone disorders associated with acromegaly: mechanisms and treatment. Eur J Endocrinol 181:45–56. https://doi.org/10.1530/EJE-19-0184
doi: 10.1530/EJE-19-0184
Calatayud M, Pérez-Olivares Martín L, Librizzi MS, Lora Pablos D, González Méndez V, Aramendi Ramos M, Martínez Diaz-Guerra G, Hawkins F (2021) Trabecular bone score and bone mineral density in patients with long-term controlled acromegaly. Clin Endocrinol 95:58–64. https://doi.org/10.1111/cen.14439
doi: 10.1111/cen.14439
Kužma M, Vaňuga P, Ságová I, Pávai D, Jackuliak P, Killinger Z, Binkley N, Winzenrieth R, Payer J (2021) Vertebral fractures occur despite control of acromegaly and are predicted by cortical volumetric bone mineral density. J Clin Endocrinol Metab 106:5088–5096. https://doi.org/10.1210/clinem/dgab259
doi: 10.1210/clinem/dgab259
Valassi E, Crespo I, Malouf J, Llauger J, Aulinas A, Marín AM, Biagetti B, Webb SM (2016) Reduction of trabecular and cortical volumetric bone mineral density at the proximal femur in patients with acromegaly. Eur J Endocrinol 174:107–114. https://doi.org/10.1530/EJE-15-0931
doi: 10.1530/EJE-15-0931
pubmed: 26530355
Giustina A, Barkan A, Beckers A, Biermasz N, Biller BMK, Boguszewski C, Bolanowski M, Bonert V, Bronstein MD, Casanueva FF, Clemmons D, Colao A, Ferone D, Fleseriu M, Frara S, GadelhaMR GE, Gurnell M, Heaney AP, KenK IA, Katznelson L, Kelestimur F, KopchickJ KM, Lamberts S, Losa M, LugerA MP, MarazuelaM MG, Mercado M, Mortini P, Neggers S, Pereira AM, Petersenn P, Puig-Domingo M, Salvatori R, Shimon I, Strasburger C, Tsagarakis S, van der Lely AJ, Wass J, Zatelli MC, Melmed S (2020) A consensus on the diagnosis and treatment of acromegaly comorbidities: an update. J Clin Endocrinol Metab 105:937–946. https://doi.org/10.1210/clinem/dgz096
doi: 10.1210/clinem/dgz096
Wassenaar MJ, Biermasz NR, Hamdy NA, Zillikens MC, van Meurs JB, Rivadeneira F, Hofman A, Uitterlinden AG, Stokkel MP, Roelfsema F, Kloppenburg M, Kroon HM, Romijn JA, Pereira AM (2011) High prevalence of vertebral fractures despite normal bone mineral density in patients with long-term controlled acromegaly. Eur J Endocrinol 164:475–483. https://doi.org/10.1530/EJE-10-1005
doi: 10.1530/EJE-10-1005
pubmed: 21257726
Claessen KM, Kroon HM, Pereira AM, Appelman-Dijkstra NM, Verstegen MJ, Kloppenburg M, Hamdy NAT, Biermasz NR (2013) Progression of vertebral fractures despite long-term biochemical control of acromegaly: a prospective follow-up study. J Clin Endocrinol Metab 98:4808–4815. https://doi.org/10.1210/jc.2013-2695
doi: 10.1210/jc.2013-2695
pubmed: 24081732
Mazziotti G, Bianchi A, Porcelli T, Mormando M, Maffezzoni F, Cristiano A, Giampietro A, De Marinis L, Giustina A (2013) Vertebral fractures in patients with acromegaly: a 3-year prospective study. J Clin Endocrinol Metab 98:3402–3410. https://doi.org/10.1210/jc.2013-1460
doi: 10.1210/jc.2013-1460
pubmed: 23771918
Pelsma ICM, Biermasz NR, Pereira AM, van Furth WR, Appelman-Dijkstra NM, Kloppenburg M, Kroon HM, Claessen KMJA (2020) Progression of vertebral fractures in long-term controlled acromegaly: a 9-year follow-up study. Eur J Endocrinol 183:427–437. https://doi.org/10.1530/EJE-20-0415
doi: 10.1530/EJE-20-0415
pubmed: 32688336
Chiloiro S, Mazziotti G, Giampietro A, Bianchi A, Frara S, Mormando M, Pontecorvi A, Giustina A, De Marinis L (2018) Effects of pegvisomant and somatostatin receptor ligands on incidence of vertebral fractures in patients with acromegaly. Pituitary 21:302–308. https://doi.org/10.1007/s11102-018-0873-7
doi: 10.1007/s11102-018-0873-7
pubmed: 29397538
Chiloiro S, Giampietro A, Frara S, Bima C, Donfrancesco F, Fleseriu CM, Pontecorvi A, Giustina A, Fleseriu M, De Marinis L, Bianchi A (2020) Effects of pegvisomant and pasireotide LAR on vertebral fractures in acromegaly resistant to first-generation SRLs. J Clin Endocrinol Metab 105:100–107. https://doi.org/10.1210/clinem/dgz054
doi: 10.1210/clinem/dgz054
Genant HK, Wu CY, van Kuijk C, Nevitt MC (1993) Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 8:1137–1148. https://doi.org/10.1002/jbmr.5650080915
doi: 10.1002/jbmr.5650080915
pubmed: 8237484
Diacinti D, Guglielmi G (2010) Vertebral morphometry. Radiol Clin North Am 48:561–575. https://doi.org/10.1016/j.rcl.2010.02.018
doi: 10.1016/j.rcl.2010.02.018
pubmed: 20609892
Mazziotti G, Battista C, Maffezzoni F, Chiloiro S, Ferrante E, Prencipe N, Grasso L, Gatto F, Olivetti R, Arosio M, Barale M, Bianchi A, Cellini M, Chiodini I, De Marinis L, Del Sindaco G, Di Somma C, Ferlin A, Ghigo E, Giampietro A, Grottoli S, Lavezzi E, Mantovani G, Morenghi E, Pivonello R, Porcelli T, Procopio M, Pugliese F, Scillitani A, Lania AG (2020) Treatment of acromegalic osteopathy in real-life clinical practice: the BAAC (bone active drugs in acromegaly) study. J Clin Endocrinol Metab 105:3285–3292. https://doi.org/10.1210/clinem/dgaa363
doi: 10.1210/clinem/dgaa363
Bogazzi F, Colao A, Rossi G, Lombardi M, Urbani C, Sardella C, Iannelli A, Scattina I, Manetti L, Del Sarto S, Pivonello R, Grasso LFS, Lupi I, Auriemma RS, Lombardi G, Martino E (2013) Comparison of the effects of primary somatostatin analogue therapy and pituitary adenomectomy on survival in patients with acromegaly: a retrospective cohort study. Eur J Endocrinol 169:367–376. https://doi.org/10.1530/EJE-13-0166
doi: 10.1530/EJE-13-0166
pubmed: 23828855
Sardella C, Cappellani D, Urbani C, Manetti L, Marconcini G, Tomisti L, Lupi I, Rossi G, Scattina I, Lombardi M, Di Bello V, Marcocci C, Martino E, Bogazzi F (2016) Disease activity and lifestyle influence comorbidities and cardiovascular events in patients with acromegaly. Eur J Endocrinol 175:443–453. https://doi.org/10.1530/EJE-16-0562
doi: 10.1530/EJE-16-0562
pubmed: 27528501
Urbani C, Sardella C, Calevro A, Rossi G, Scattina I, Lombardi M, Lupi I, Manetti L, Martino E, Bogazzi F (2013) Effects of medical therapies for acromegaly on glucose metabolism. Eur J Endocrinol 169:99–108. https://doi.org/10.1530/EJE-13-0032
doi: 10.1530/EJE-13-0032
pubmed: 23660641
Colao A, Ferone D, Marzullo P, Lombardi G (2004) Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocr Rev 25:102–152. https://doi.org/10.1210/er.2002-0022
doi: 10.1210/er.2002-0022
pubmed: 14769829
Maione L, Brue T, Beckers A, Delemer B, Petrossians P, Borson-Chazot F, Chabre O, François P, Bertherat J, Cortet-Rudelli C, Chanson P (2017) Changes in the management and comorbidities of acromegaly over three decades: the French acromegaly registry. Eur J Endocrinol 176:645–655. https://doi.org/10.1530/EJE-16-1064
doi: 10.1530/EJE-16-1064
pubmed: 28246150
Giustina A, Barkhoudarian G, Beckers A, Ben-Shlomo A, Biermasz N, Biller B, Boguszewski C, Bolanowski M, Bollerslev J, Bonert V, Bronstein MD, Buchfelder M, Casanueva F, Chanson P, Clemmons D, Fleseriu M, Formenti AM, Freda P, Gadelha M, Geer E, Gurnell M, Heaney AP, Ho KKY, Ioachimescu AG, Lamberts S, Laws E, Losa M, Maffei P, Mamelak A, Mercado M, Molitch M, Mortini P, Pereira AM, Petersenn S, Post K, Puig-Domingo M, Salvatori R, Samson SL, Shimon I, Strasburger C, Swearingen B, Trainer P, Vance ML, Wass J, Wierman ME, Yuen KCJ, Zatelli MC, Melmed S (2020) Multidisciplinary management of acromegaly: a consensus. Rev Endocr Metab Disord 21:667–678. https://doi.org/10.1007/s11154-020-09588-z
doi: 10.1007/s11154-020-09588-z
pubmed: 32914330
pmcid: 7942783
Chiloiro S, Giampietro A, Gagliardi I, Bondanelli M, Veleno M, Ambrosio MR, Zatelli MC, Pontecorvi A, Giustina A, De Marinis L, Bianchi A (2022) Impact of the diagnostic delay of acromegaly on bone health: data from a real life and long term follow-up experience. Pituitary 3:1–11. https://doi.org/10.1007/s11102-022-01266-4
doi: 10.1007/s11102-022-01266-4
Mazziotti G, Baracca M, Doga M, Porcelli T, Vescovi PP, Giustina A (2012) Prevalence of thoracic vertebral fractures in hospitalized elderly patients with heart failure. Eur J Endocrinol 167:865–872. https://doi.org/10.1530/EJE-12-0566
doi: 10.1530/EJE-12-0566
pubmed: 22968484
Majumdar SR, Kim N, Colman I, Chahal AM, Raymond G, Jen H, Siminoski KG, Hanley DA, Rowe BH (2005) Incidental vertebral fractures discovered with chest radiography in the emergency department: prevalence, recognition, and osteoporosis management in a cohort of elderly patients. Arch Intern Med 165:905–909. https://doi.org/10.1001/archinte.165.8.905
doi: 10.1001/archinte.165.8.905
pubmed: 15851642
van der Jagt-Willems HC, van Munster BC, Leeflang M, Beuerle E, Tulner CR, Lems WF (2014) Diagnosis of vertebral fractures on lateral chest X-ray: intraobserver agreement of semi-quantitative vertebral fracture assessment. Eur J Radiol 83:2177–2180. https://doi.org/10.1016/j.ejrad.2014.09.005
doi: 10.1016/j.ejrad.2014.09.005
pubmed: 25445898
Li Y, Yan L, Cai S, Wang P, Zhuang H, Yu H (2018) The prevalence and under-diagnosis of vertebral fractures on chest radiograph. BMC Musculoskelet Disord 19:235. https://doi.org/10.1186/s12891-018-2171-y
doi: 10.1186/s12891-018-2171-y
pubmed: 30021567
pmcid: 6052683
Frara S, Uygur MM, di Filippo L, Doga M, Losa M, Santoro S, Mortini P, Giustina A (2022) High prevalence of vertebral fractures associated with preoperative GH levels in patients with recent diagnosis of acromegaly. J Clin Endocrinol Metab 107:2843–2850. https://doi.org/10.1210/clinem/dgac183
doi: 10.1210/clinem/dgac183
Lentle B, Koromani F, Brown JP, Oei L, Ward L, Goltzman D, Rivadeneira F, Leslie WD, Probyn L, Prior J, Hammond I, Cheung AM, Oei EH (2019) The radiology of osteoporotic vertebral fractures revisited. J Bone Miner Res 34:409–418. https://doi.org/10.1002/jbmr.3669
doi: 10.1002/jbmr.3669
pubmed: 30645770
Sanfélix-Genovés J, Arana E, Sanfélix-Gimeno G, Peiró S, Graells-Ferrer M, Vega-Martínez M (2012) Agreement between semi-automatic radiographic morphometry and Genant semi-quantitative method in the assessment of vertebral fractures. Osteoporos Int 23:2129–2134. https://doi.org/10.1007/s00198-011-1819-3
doi: 10.1007/s00198-011-1819-3
pubmed: 22170523
Fechtenbaum J, Cropet C, Kolta S, Verdoncq B, Orcel P, Roux C (2005) Reporting of vertebral fractures on spine X-rays. Osteoporos Int 16:1823–1826. https://doi.org/10.1007/s00198-005-1939-8
doi: 10.1007/s00198-005-1939-8
pubmed: 16032373
Bioletto F, Barale M, Prencipe N, Berton AM, Parasiliti-Caprino M, Gasco V, Ghigo E, Procopio M, Grottoli S (2022) Trabecular bone score as an index of bone fragility in patients with acromegaly: a systematic review and meta-analysis. Neuroendocrinology 113:395–405. https://doi.org/10.1159/000528199
doi: 10.1159/000528199
pubmed: 36617407
Plard C, Hochman C, Hadjadj S, Le Goff B, Maugars Y, Cariou B, Drui D, Guillot P (2020) Acromegaly is associated with vertebral deformations but not vertebral fractures: results of a cross-sectional monocentric study. Joint Bone Spine 87:618–624. https://doi.org/10.1016/j.jbspin.2020.04.020
doi: 10.1016/j.jbspin.2020.04.020
pubmed: 32428690
Cellini M, Biamonte E, Mazza M, Trenti N, Ragucci P, Milani D, Ferrante E, Rossini Z, Lavezzi E, Sala E, Mantovani G, Arosio M, Fornari M, Balzarini L, Lania AG, Mazziotti G (2021) Vertebral fractures associated with spinal sagittal imbalance and quality of life in acromegaly: a radiographic study with EOS 2D/3D technology. Neuroendocrinology 111:775–785. https://doi.org/10.1159/000511811
doi: 10.1159/000511811
pubmed: 32980840
Battista C, Chiodini I, Muscarella S, Guglielmi G, Mascia ML, Carnevale V, Scillitani A (2009) Spinal volumetric trabecular bone mass in acromegalia patients: a longitundinal study. Clin Endocrinol 70:378–382. https://doi.org/10.1111/j.1365-2265.2008.03322.x
doi: 10.1111/j.1365-2265.2008.03322.x
Bhasin S, Brito JP, Cunningham GR, Hayes FJ, Hodis HN, Matsumoto AM, Snyder PJ, Swerdloff RS, Wu FC, Yialamas MA (2018) Testosterone therapy in men with hypogonadism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 103:1715–1744. https://doi.org/10.1210/jc.2018-00229
doi: 10.1210/jc.2018-00229
pubmed: 29562364
Mazziotti G, Lania AG, Canalis E (2022) Skeletal disorders associated with the growth hormone-insulin-like growth factor 1 axis. Nat Rev Endocrinol 18:353–365. https://doi.org/10.1038/s41574-022-00649-8
doi: 10.1038/s41574-022-00649-8
pubmed: 35288658
Vitali E, Palagano E, Schiavone ML, Mantovani G, Sobacchi C, Mazziotti G, Lania A (2022) Direct effects of octreotide on osteoblast cell proliferation and function. J Endocrinol Invest 45:1045–1057. https://doi.org/10.1007/s40618-022-01740-7
doi: 10.1007/s40618-022-01740-7
pubmed: 35020172